Innovation, Moonshots, Brain, Healthtech, Stroke.
will take up most of 2022 and, if everything goes as planned, they’ll be buttoning up their FDA approval in 2023. Finally, we’re excited to back Neuralert because it is health moonshot entrepreneurship at its best. Co-founder Dr. Steven Messé saw a terrible problem — people becoming disabled from